Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.

Carcinogenesis - 1 Feb 2005

Bartling Babett, Hofmann Hans-Stefan, Weigle Bernd, Silber Rolf-Edgar, Simm Andreas

Abstract excerpt

The receptor for advanced glycation end-products (RAGE) is a transmembrane receptor of the immunoglobulin superfamily. Several ligands binding to RAGE have been identified, including amphoterin. Experimental studies have given rise to the discussion that RAGE and its interaction with amphoterin c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cell Proliferation
Share to Collagen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Down-Regulation

Share to Lung Neoplasms

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 15539404
DOI: 10.1093/carcin/bgh333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15539404-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma.PMID 15539404Read ↗

Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancerSemantic proximity Read ↗

RAGE may act as a tumour suppressor to regulate lung cancer development.Semantic proximity Read ↗

A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer.Semantic proximity Read ↗

Truncated RON Tyrosine Kinase Drives Tumor Cell Progression and Abrogates Cell-Cell Adhesion Through E-Cadherin Transcriptional RepressionSemantic proximity Read ↗

HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.Semantic proximity Read ↗

Conditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation.Semantic proximity Read ↗

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.Semantic proximity Read ↗

Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA.Semantic proximity Read ↗

Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential displaySemantic proximity Read ↗

Caveolae as a target to quench autoinduction of the metastatic phenotype in lung cancer.Semantic proximity Read ↗

Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosisSemantic proximity Read ↗

Expression of CD44 in human lung tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.